Cost-effectiveness of pegfilgrastim versus 6-day filgrastim primary prophylaxis in patients with non-Hodgkin's lymphoma receiving CHOP-21 in United States.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples